BIOGEN INC. Goodwill, Other Changes (Deprecated 2016-01-31)
BIOGEN INC. (BIIB) reported Goodwill, Other Changes (Deprecated 2016-01-31) of -$4.50 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-03.
Discontinued › Notes › Intangible Assets
us-gaap:GoodwillOtherChanges · last filed 2016-02-03
- BIOGEN INC. goodwill, other changes (deprecated 2016-01-31) for the quarter ending 2015-12-31 was -$3.80M.
- BIOGEN INC. goodwill, other changes (deprecated 2016-01-31) for the quarter ending 2015-09-30 was -$4.80M.
- BIOGEN INC. goodwill, other changes (deprecated 2016-01-31) for the quarter ending 2015-06-30 was $6.80M.
- BIOGEN INC. goodwill, other changes (deprecated 2016-01-31) for the quarter ending 2015-03-31 was -$2.70M.
- BIOGEN INC. goodwill, other changes (deprecated 2016-01-31) for fiscal 2015 was -$4.50M.
- BIOGEN INC. goodwill, other changes (deprecated 2016-01-31) for fiscal 2014 was $0.00.
- BIOGEN INC. goodwill, other changes (deprecated 2016-01-31) for fiscal 2010 was $17.90M.
| Period end | Goodwill, Other Changes (Deprecated 2016-01-31) 3 month | Goodwill, Other Changes (Deprecated 2016-01-31) 6 month | Goodwill, Other Changes (Deprecated 2016-01-31) 9 month | Goodwill, Other Changes (Deprecated 2016-01-31) 12 month |
|---|---|---|---|---|
| 2015-12-31 | -$3.80M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-03 | -$8.60M derived: sum of 2 quarters · filed 2016-02-03 | -$1.80M derived: sum of 3 quarters · filed 2016-02-03 | -$4.50M 10-K · filed 2016-02-03 |
| 2015-09-30 | -$4.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-21 | $2.00M derived: sum of 2 quarters · filed 2015-10-21 | -$700.00K 10-Q · filed 2015-10-21 | -$700.00K derived: sum of 4 quarters · filed 2016-02-03 |
| 2015-06-30 | $6.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-24 | $4.10M 10-Q · filed 2015-07-24 | $4.10M derived: sum of 3 quarters · filed 2016-02-03 | $4.10M derived: sum of 4 quarters · filed 2016-02-03 |
| 2015-03-31 | -$2.70M 10-Q · filed 2015-04-24 | -$2.70M derived: sum of 2 quarters · filed 2016-02-03 | -$2.70M derived: sum of 3 quarters · filed 2016-02-03 | |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-03 | $0.00 derived: sum of 2 quarters · filed 2016-02-03 | $0.00 10-K · filed 2016-02-03 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-22 | $0.00 10-Q · filed 2014-10-22 | ||
| 2014-06-30 | $0.00 10-Q · filed 2014-07-23 | |||
| 2013-12-31 | -$4.10M 10-Q · filed 2014-10-22 | |||
| 2010-12-31 | $17.90M 10-K · filed 2012-02-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |